Long-term survival and local relapse following surgery without radiotherapy for locally advanced upper rectal cancer

Medicine (United States)

Volumn 95, Issue 22, 2016, Pages

  Park, Jun Seok ^a   Sakai, Yoshiharu ^b   Simon, NG Siu Man ^c   Law, Wai Lun ^d   Kim, Hyeong Rok ^e   Oh, Jae Hwan ^f   Shan, Hester Cheung Yui ^g   Kwak, Sang Gyu ^h   Choi, Gyu Seog ^a  

^a Kyungpook National University School of Medicine   (South Korea)

^b KYOTO UNIVERSITY HOSPITAL   (Japan)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^d UNIVERSITY OF HONG KONG   (Hong Kong)

^e Chonnam National University   (South Korea)

^f National Cancer Center Hospital   (South Korea)

^g PAMELA YOUDE NETHERSOLE EASTERN HOSPITAL   (Hong Kong)

^h Catholic University of Daegu   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; CAPECITABINE PLUS OXALIPLATIN; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; COHORT ANALYSIS; COLON CANCER; CONTROLLED STUDY; DATA BASE; DISEASE FREE SURVIVAL; DISEASE SEVERITY; FEMALE; HUMAN; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RECTUM CANCER; RECURRENCE RISK; SURVIVAL RATE; TUMOR INVASION; TUMOR VOLUME; CANCER STAGING; CLINICAL TRIAL; COLON RESECTION; EPIDEMIOLOGY; FOLLOW UP; INCIDENCE; MORTALITY; MULTICENTER STUDY; PROCEDURES; PROGNOSIS; RECTAL NEOPLASMS; RETROSPECTIVE STUDY; SOUTH KOREA; TIME FACTOR; TRENDS; TUMOR RECURRENCE;

COLECTOMY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RECTAL NEOPLASMS; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS;

EID: 84975321895     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000002990     Document Type: Article

References (32)

1. Enker WE. Total mesorectal excision-The new golden standard of surgery for rectal cancer. Ann Med. 1997; 29: 127-133
2. MacFarlane JK, Ryall RD, Heald RJ. Mesorectal excision for rectal cancer. Lancet. 1993; 341: 457-460
3. Bosset JF, Collette L, Calais G, et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med. 2006; 355: 1114-1123
4. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001; 345: 638-646
5. Sauer R, Liersch T, Merkel S, et al. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years. J Clin Oncol. 2012; 30: 1926-1933
6. Sebag-Montefiore D, Stephens RJ, Steele R, et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet. 2009; 373: 811-820
7. van Gijn W, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol. 2011; 12: 575-582
8. Pahlman L, Glimelius B. Pre-or postoperative radiotherapy in rectal and rectosigmoid carcinoma. Report from a randomized multicenter trial. Ann Surg. 1990; 211: 187-195
9. Engstrom PF, Arnoletti JP, Benson AB 3rd, et al. NCCN Clinical Practice Guidelines in Oncology: rectal cancer. J Natl Compr Canc Netw. 2009; 7: 838-881
10. Rodel C, Liersch T, Hermann RM, et al. Multicenter phase II trial of chemoradiation with oxaliplatin for rectal cancer. J Clin Oncol. 2007; 25: 110-117
11. Arbea L, Martinez-Monge R, Diaz-Gonzalez JA, et al. Four-week neoadjuvant intensity-modulated radiation therapy with concurrent capecitabine and oxaliplatin in locally advanced rectal cancer patients: a validation phase II trial. Int J Radiat Oncol Biol Phys. 2012; 83: 587-593
12. Crosby T, Hurt CN, Falk S, et al. Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial. Lancet Oncol. 2013; 14: 627-637
13. Bosset JF, Calais G, Mineur L, et al. Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results-EORTC 22921. J Clin Oncol. 2005; 23: 5620-5627
14. Nelson H, Petrelli N, Carlin A, et al. Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst. 2001; 93: 583-596
15. Pilipshen SJ, Heilweil M, Quan SH, et al. Patterns of pelvic recurrence following definitive resections of rectal cancer. Cancer. 1984; 53: 1354-1362
16. Kang SB, Park JW, Jeong SY, et al. Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-Term outcomes of an open-label randomised controlled trial. Lancet Oncol. 2010; 11: 637-645
17. Law WL, Chu KW. Anterior resection for rectal cancer with mesorectal excision: a prospective evaluation of 622 patients. Ann Surg. 2004; 240: 260-268
18. Park JS, Choi GS, Jun SH, et al. Laparoscopic versus open intersphincteric resection and coloanal anastomosis for low rectal cancer: intermediate-Term oncologic outcomes. Ann Surg. 2011; 254: 941-946
19. Matsumoto T, Ohue M, Sekimoto M, et al. Feasibility of autonomic nerve-preserving surgery for advanced rectal cancer based on analysis of micrometastases. Br J Surg. 2005; 92: 1444-1448
20. Lopez-Kostner F, Lavery IC, Hool GR, et al. Total mesorectal excision is not necessary for cancers of the upper rectum. Surgery. 1998; 124: 612-617
21. Fujita S, Yamamoto S, Akasu T, et al. Lateral pelvic lymph node dissection for advanced lower rectal cancer. Br J Surg. 2003; 90: 1580-1585
22. Koch M, Kienle P, Antolovic D, et al. Is the lateral lymph node compartment relevant? Recent Results Cancer Res. 2005; 165: 40-45
23. Kim TH, Jeong SY, Choi DH, et al. Lateral lymph node metastasis is a major cause of locoregional recurrence in rectal cancer treated with preoperative chemoradiotherapy and curative resection. Ann Surg Oncol. 2008; 15: 729-737
24. Takahashi T, Ueno M, Azekura K, et al. Lateral node dissection and total mesorectal excision for rectal cancer. Dis Colon Rectum. 2000; 43: S59-68
25. Ueno H, Mochizuki H, Hashiguchi Y, et al. Prognostic determinants of patients with lateral nodal involvement by rectal cancer. Ann Surg. 2001; 234: 190-197
26. Koda K, Saito N, Oda K, et al. Evaluation of lateral lymph node dissection with preoperative chemo-radiotherapy for the treatment of advanced middle to lower rectal cancers. Int J Colorectal Dis. 2004; 19: 188-194
27. Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med. 1997; 336: 980-987
28. Fietkau R, Klautke G. Adjuvant chemotherapy following neoadjuvant therapy of rectal cancer: the type of neoadjuvant therapy (chemoradiotherapy or radiotherapy) may be important for selection of patients. J Clin Oncol. 2008; 26: 507-508
29. Minsky BD. Adjuvant management of rectal cancer: the more we learn, the less we know. J Clin Oncol. 2007; 25: 4339-4340
30. Yun HR, Chun HK, Lee WS, et al. Intra-operative measurement of surgical lengths of the rectum and the peritoneal reflection in Korean. J Korean Med Sci. 2008; 23: 999-1004
31. Memon S, Keating JP, Cooke HS, et al. A study into external rectal anatomy: improving patient selection for radiotherapy for rectal cancer. Dis Colon Rectum. 2009; 52: 87-90
32. Najarian MM, Belzer GE, Cogbill TH, et al. Determination of the peritoneal reflection using intraoperative proctoscopy. Dis Colon Rectum. 2004; 47: 2080-2085